Coredio Receives FDA Breakthrough Device Designation for CPSE and Acceptance into the FDA TAP Program
May 28, 2026
No Comments
FDA Breakthrough Device Designation Combining personalized calibration, wearables, and AI for proactive heart failure care. FDA BREAKTHROUGH DEVICE • TAP